Blastoid Variant Mantle Cell Lymphoma
4 clinical trials · Condition
◉ Watch Blastoid Variant Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT03946878) | M.D. Anderson Cancer Center | 2019-08-13 |
| Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant (NCT02869633) | Vanderbilt-Ingram Cancer Center | 2016-11-01 |
| Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT02427620) | M.D. Anderson Cancer Center | 2015-06-03 |
Track Blastoid Variant Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.